source
- How cost and perception could reshape the GLP-1 marketAs Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help decide the winners.BioPharma Dive · 34m ago↗ source
- Moderna’s melanoma vaccine trial success sparks $45 billion market value surgeModerna’s shares jumped more than 170% after the company announced that its experimental melanoma vaccine, intismeran, met its primary goals in a Phase 3 trial. The surge added roughly $45 billion…